DEFINING THE PREVALENCE AND CHARACTERISTICS OF CORONARY ARTERY DISEASE AMONG PATIENTS WITH TYPE 2 MYOCARDIAL INFARCTION USING CT-FFR (DEFINE TYPE 2 MI) von McCarthy, Cian P., Murphy, Sean P., Miksenas, Hannah, Amponsah, Daniel, Rambarat, Paula, Levin, Allison, Raghavan, Avanthi, Mohebi, Reza, Lin, Claire, Rogers, Campbell D.K., Wasfy, Jason H., Blankstein, Ron, Ghoshhajra, Brian B., Hedgire, Sandeep, Januzzi, James L.

Volltext

No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention von Resnic, Frederic S., Wainstein, Marco, Lee, Michael K.Y., Behrendt, Dominik, Wainstein, Rodrigo V., Ohno-Machado, Lucila, Kirshenbaum, James M., Rogers, Campbell D.K., Popma, Jeffrey J., Piana, Robert

Volltext

Optimal stent design for drug delivery von Rogers, Campbell D K

Volltext

Drug-eluting stents: clinical perspectives on drug and design differences von Rogers, Campbell D K

Volltext

Drug-eluting stents: role of stent design, delivery vehicle, and drug selection von Rodgers, Campbell D K

Volltext